Get started
Author

Dennis J. Donohoe

Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group.
1996 · D L Steed, D Donohoe, et al. · PubMed · 576
Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions.
2005 · Patrick W Serruys, Andrew T L Ong, et al. · PubMed · 170
Wire-Interwoven Nitinol Stent Outcome in the Superficial Femoral and Proximal Popliteal Arteries
2015 · Lawrence Garcia, Michael R. Jaff, et al. · Circulation Cardiovascular Interventions · 156
PDF
The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II)
2007 · K. Tsuchida, A. Colombo, et al. · European Heart Journal · 137
Carotid artery stenting with emboli protection surveillance study: Thirty‐day results of the CASES‐PMS study
2007 · Barry T. Katzen, Frank J. Criado, et al. · Catheterization and Cardiovascular Interventions · 119
Relationship of Late Loss in Lumen Diameter to Coronary Restenosis in Sirolimus-Eluting Stents
2005 · Laura Mauri, E. John Orav, et al. · Circulation · 108
PDF
The Nitinol SMART Stent vs Wallstent for Suboptimal Iliac Artery Angioplasty: CRISP-US Trial Results
2004 · Donald Ponec, Michael R. Jaff, et al. · Journal of Vascular and Interventional Radiology · 102
Periprocedural and Late Consequences of Overlapping Cypher Sirolimus-Eluting Stents
2006 · Dean J. Kereiakes, Hong Wang, et al. · Journal of the American College of Cardiology · 91
Sirolimus-Eluting Stents at Two Years: A Pooled Analysis of SIRIUS, E-SIRIUS, and C-SIRIUS With Emphasis on Late Revascularizations and Stent Thromboses
2006 · Erick Schampaert, Jeffrey W. Moses, et al. · The American Journal of Cardiology · 85
Drug-Eluting Stents in the Treatment of Intermediate Lesions
2006 · Jeffrey W. Moses, Gregg W. Stone, et al. · Journal of the American College of Cardiology · 72
PDF
Randomised study of a bioabsorbable polymer-coated sirolimus-eluting stent: results of the DESSOLVE II trial
2015 · William Wijns, Mathias Vrolix, et al. · EuroIntervention · 40
First-in-Human Evaluation of a Bioabsorbable Polymer–Coated Sirolimus-Eluting Stent
2013 · John Ormiston, Mark Webster, et al. · JACC: Cardiovascular Interventions · 40
PDF
Postmarket evaluation of breakthrough technologies
2008 · Sunil V. Rao, Robert M. Califf, et al. · American Heart Journal · 38
Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis of the GAMMA I Randomized Trial)
2002 · Jeffrey W Moses, Issam Moussa, et al. · The American Journal of Cardiology · 28
Adventitial Drug Delivery of Dexamethasone to Improve Primary Patency in the Treatment of Superficial Femoral and Popliteal Artery Disease
2018 · Mahmood K. Razavi, Dennis Donohoe, et al. · JACC: Cardiovascular Interventions · 27
PDF
One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease.Sirolimus stent vs. coronary artery bypass surgery and bare metal stent: insights from ARTS-II and ARTS-I.
2006 · Carlos Macaya, Héctor M García-García, et al. · PubMed · 25
PDF
Evaluation of a crystalline sirolimus-eluting coronary stent with a bioabsorbable polymer designed for rapid dissolution: two-year outcomes from the DESSOLVE I and II trials
2016 · William Wijns, Maarten Jan Suttorp, et al. · EuroIntervention · 22
Carotid Artery Stenting With Emboli Protection Surveillance Study
2010 · Theodore L. Schreiber, Neil Strickman, et al. · Journal of the American College of Cardiology · 20
Long-term clinical outcomes of a crystalline sirolimus-eluting coronary stent with a fully bioabsorbable polymer coating: five-year outcomes from the DESSOLVE I and II trials
2018 · William Wijns, Mathias Vrolix, et al. · EuroIntervention · 18
Serial Assessment by Optical Coherence Tomography of Early and Late Vascular Responses After Implantation of an Absorbable-Coating Sirolimus-Eluting Stent (from the First-in-Human DESSOLVE I Trial)
2013 · Guilherme F. Attizzani, Hiram G. Bezerra, et al. · The American Journal of Cardiology · 17
Evaluation of the MiStent sustained sirolimus eluting biodegradable polymer coated stent for the treatment of coronary artery disease: does uniform sustained abluminal drug release result in earlier strut coverage and better safety profile?
2017 · Ruben Y.G. Tijssen, Robin P. Kraak, et al. · Expert Review of Medical Devices · 10
PDF
Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus‐eluting stents
2008 · Eugenia Nikolsky, David R. Holmes, et al. · Catheterization and Cardiovascular Interventions · 9
Bioabsorbable polymer‐coated sirolimus‐eluting stent implantation preserves coronary vasomotion: A DESSOLVE II trial sub‐study
2014 · Dan Rusinaru, Mathias Vrolix, et al. · Catheterization and Cardiovascular Interventions · 6
Technical overview on the MiStent coronary stent.
2016 · James B McCLAIN, Wenda C Carlyle, et al. · PubMed · 1
CRT-300.17 Transverse View Area Loss (TVAL): An Informative Angiographic Outcome in Below-Knee Lesions
2020 · Ehrin J. Armstrong, Dierk Scheinert, et al. · JACC: Cardiovascular Interventions
Works count: 30
Citation count: 1,917
H-index: 18
I10-index: 21
Year
Topic
Type